Zealand Pharma A/S (ZLDPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -156,430 | -116,121 | -75,238 | -33,291 | -102,183 |
| Depreciation Amortization | 3,748 | 2,885 | 1,931 | 964 | 3,643 |
| Accounts receivable | -7,099 | -8,600 | -2,366 | 1,845 | -981 |
| Accounts payable and accrued liabilities | 13,038 | -1,018 | 5,383 | 487 | 5,784 |
| Other Working Capital | 17,745 | -1,733 | 644 | -664 | 7,565 |
| Other Operating Activity | -5,969 | 13,986 | 3,989 | -1,907 | 24,365 |
| Operating Cash Flow | $-134,968 | $-110,600 | $-65,657 | $-32,567 | $-61,807 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,061,366 | -1,101,595 | -201,916 | -200,191 | -155,405 |
| PPE Investments | -1,458 | -1,309 | -1,245 | -514 | -1,632 |
| Purchase Sale Intangibles | -449 | -188 | -143 | N/A | -1,816 |
| Other Investing Activity | -449 | -189 | -143 | 0 | -1,816 |
| Investing Cash Flow | $-1,063,273 | $-1,103,092 | $-203,304 | $-200,705 | $-158,854 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 53,631 | 54,518 | 53,372 | 53,853 | N/A |
| Common Stock Issued | 1,235,904 | 1,256,349 | 1,229,190 | 215,276 | 227,086 |
| Common Stock Repurchased | -51,016 | -51,860 | -11,693 | N/A | -6,040 |
| Other Financing Activity | -36,688 | -36,605 | -34,891 | -3,903 | -89,347 |
| Financing Cash Flow | $1,201,831 | $1,222,402 | $1,235,978 | $265,226 | $131,698 |
| Exchange Rate Effect | 904 | 385 | 659 | 527 | -1,051 |
| Beginning Cash Position | 65,150 | 66,228 | 64,836 | 65,420 | 155,253 |
| End Cash Position | 69,644 | 75,324 | 1,032,512 | 97,901 | 65,240 |
| Net Cash Flow | $4,494 | $9,096 | $967,676 | $32,481 | $-90,013 |
| Free Cash Flow | |||||
| Operating Cash Flow | -134,968 | -110,600 | -65,657 | -32,567 | -61,807 |
| Capital Expenditure | -1,458 | -1,309 | -1,245 | -514 | -1,632 |
| Free Cash Flow | -136,426 | -111,909 | -66,902 | -33,081 | -63,439 |